胎盘增长频谱 预防性治疗用于使用特兰克萨姆酸的高纤维素溶解
Tiyasha Hosne Ayub1, Brigitte Strizek1, Bernd Poetzsch2
1Department of Obstetrics and Prenatal Medicine, University Hospital Bonn, Venusberg Campus 1, 53127 Bonn, Germany.
Journal of clinical medicine
|January 11, 2024
概括
预期的管理 (EM) 是一个安全的选择,胎盘增生谱系 (PAS) 障碍. 用特兰胺酸 (TXA) 进行预防性治疗,有效地治疗PAS患者在EM期间的纤维素分解和出血.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 流血性疾病 流血性疾病
背景情况:
- 胎盘增生频谱 (PAS) 提出了管理方面的挑战.
- 过敏纤维素溶解在PAS的预期管理 (EM) 期间是一个重要的风险.
- 特兰胺酸 (TXA) 是一种潜在的预防疗法.
研究的目的:
- 评估预防性特兰胺酸 (TXA) 对于在胎盘增生谱 (PAS) 中预期管理 (EM) 期间的高纤维素溶解的安全性和有效性.
主要方法:
- 在2005-2021年间对35名PAS患者进行单心回顾性研究.
- 从部门数据库追溯收集的数据.
- 分析预期的管理结果,高纤维素溶解发作和TXA治疗疗效.
主要成果:
- 预期管理 (EM) 计划为25名患者.
- 保护子宫的治疗在72%的患者中是成功的.
- 超纤维解酶的特兰克萨姆酸 (TXA) 治疗显示,纤维素水平平均下降了29.7%.
结论:
- 预期管理 (EM) 是一个可行的和安全的治疗胎盘增殖谱 (PAS).
- 特兰胺酸 (TXA) 在EM期间有效地控制高纤维素分解和相关出血.
- 这项研究是第一个证明成功的凝血监测和TXA在EM中用于PAS的研究.
关键词:
D-二聚子 D-二聚子扩散的血管内凝血病是传播的.期待着管理层的管理.纤维素原体是有纤维的超纤维素溶解 (hyperfibrinolysis) 是一种超纤维素溶解.胎盘的增生光谱 胎盘增生光谱特兰克萨姆酸是什么意思更多相关视频
09:52Accurate and Simple Evaluation of Vascular Anastomoses in Monochorionic Placenta using Colored Dye
Published on: September 5, 2011
26.9K
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
9.7K
相关概念视频
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
